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Aging in worms and flies is regulated by the PI3K/
Akt/Foxo pathway. Here we extend this paradigm to
mammals. Ptentg mice carrying additional genomic
copies ofPten are protected fromcancer and present
a significant extension of life span that is independent
of their lower cancer incidence. Interestingly, Ptentg
mice have an increased energy expenditure and
protection from metabolic pathologies. The brown
adipose tissue (BAT) of Ptentg mice is hyperactive
and presents high levels of the uncoupling protein
Ucp1, which we show is a target of Foxo1. Impor-
tantly, a synthetic PI3K inhibitor also increases
energy expenditure and hyperactivates the BAT in
mice. These effects can be recapitulated in isolated
brown adipocytes and, moreover, implants of Ptentg
fibroblasts programmed with Prdm16 and Cebpb
form subcutaneous brown adipose pads more
efficiently than wild-type fibroblasts. These observa-
tions uncover a role of Pten in promoting energy
expenditure, thus decreasing nutrient storage and
its associated damage.
INTRODUCTION
Tumor suppressors are best known for their ability to provide
organisms with protection against cancer. At a deeper level,
however, tumor suppressors appear to protect cells from many
types of damage not necessarily related to cancer. In this regard,
an emerging theme in the study of tumor suppressors is their
pleiotropic beneficial effects on multiple aspects of physiology,
including aging (Serrano andBlasco, 2007). Evidence for a simul-
taneous protection from cancer and aging exists for tumor
suppressors p53, Ink4a, and Arf (Matheu et al., 2007, 2009).382 Cell Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc.Here we have set to test this paradigm for the tumor suppressor
Pten. Together, Pten, p53, Ink4a, and Arf constitute the four
most important tumor suppressors in mammals as reflected by
their overall high frequency of inactivation in a wide range of
cancer types.
The most prominent function of Pten is to counteract the
activity of phosphatidylinositol 3-kinase type I (PI3K) (Chalhoub
and Baker, 2009). These kinases mediate signals triggered by
insulin, insulin-like growth factors, and other molecules generally
involved in cellular growth, metabolism, survival, and prolifera-
tion. Activation of PI3K is followed by the activation of Akt, which
in turn triggers a complex cascade of events that include the inhi-
bition of Foxo transcription factors aswell as feedback loops that
ensure that the activity of the pathway is kept within limits
(Carracedo and Pandolfi, 2008; Kamagate et al., 2010; Matsu-
moto et al., 2006; Puig and Tjian, 2005; Um et al., 2006). A
number of genetically modified animals with decreased activity
of the insulin and Igf1 signaling (IIS) axis are characterized by
an extended longevity (Fontana et al., 2010; Kenyon, 2010). In
the case of the nematode Caenorhabditis elegans, both
decreased PI3K (AGE-1) activity and increased Pten (DAF-18)
expression result in extended longevity (Dorman et al., 1995;
Masse et al., 2005; Morris et al., 1996). In the case of mammals,
a variety of mice with decreased IIS activity have an extended
longevity (Bartke, 2008). Also, caloric restriction (CR) is a robust
antiaging intervention (Fontana et al., 2010), which, in mice, has
been associated with decreased levels of Igf1 and reduced basal
levels of PI3K pathway activity (Hempenstall et al., 2010; Jiang
et al., 2008; Moore et al., 2008). However, direct inhibition of
PI3K/Akt in mice has not been informative regarding longevity,
because severe inhibition of these kinases results in pathological
defects, diseases, and premature lethality (Renner and Carnero,
2009).
Here we have performed transgenesis with a large genomic
segment carrying the intact Pten gene in a bacterial artificial
chromosome (BAC). This has allowed us to increase the gene
dosage of Pten and obtain a homogeneous and moderate over-
expression of Pten while retaining its normal pattern of tissue
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Figure 1. Characterization of Ptentg Mice
(A) Relative Pten mRNA levels of the indicated tissues.
Bars represent mean ± SD (n = 3 per genotype). Statistical
significance was determined by the two-tailed Student’s
t test.
(B) Immunoblot of the indicated proteins in growing
cultures of primary MEFs. Each lane corresponds to an
independent MEF preparation.
(C) Lysates from normal growing (C), serum starved (), or
starved and stimulated with insulin (+) immunoblotted to
detect the indicated proteins.
(D) Primary MEFs (23 104) were plated at very low density,
and the number of colonies was scored 3 weeks after.
Bars represent mean ± SD (n = 3 independent MEF
preparations per genotype). Representative plates are
shown in the top. Statistical significance was determined
by the two-tailed Student’s t test.
(E) Primary MEFs were serially cultured (according to the
3T3 protocol) and the number of accumulated population
doublings is scored at each passage. Values correspond
to themean ± SD (n = 3 independent MEF preparations per
genotype). Statistical significance was determined by the
two-tailed Student’s t test.
(F) Neoplastic foci in MEFs retrovirally transduced with the
viral oncoprotein E6 and either one of the indicated PI3K-
dependent oncogenes, EGFRL858R or polyoma virus
middle-T. Bars represent mean ± SD (n = 3 independent
MEF preparations per genotype). Representative plates
are shown in the top. Statistical significance was deter-
mined by the two-tailed Student’s t test.
(G) Chemical carcinogenesis with 3-methyl-cholanthrene
(3MC). Tumor-free Kaplan-Meier curves. Time is post-
3MC injection. Statistical significance was determined by
the log rank test.
(H) Incidence of cancers. Percentage of mice with one
malignant tumor, or more (2–4), as indicated (left).
Percentage of mice with the indicated type of tumor
(right). Statistical significance was determined by the
Fisher’s exact test.
*p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S1.
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Pten Regulates Longevity and Brown Adipose Tissueexpression. An important additional benefit of BAC transgenesis
is that it allows the discovery of new physiological functions that
may not be uncovered using other approaches such as gene
deletion or tissue-restricted overexpression. Additionally, BAC
transgenesis models the effects of a systemic pharmacological
intervention aimed at enhancing Pten activity. This is particularly
relevant given the current development of pharmacologically
active small compound PI3K inhibitors. In this work, we report
the discovery of an unsuspected function of Pten in the regula-
tion of brown adipose function, energy expenditure, and protec-
tion from metabolic damage.
RESULTS
Ptentg Mice Are Protected from Cancer
To augment Pten activity without incurring overt imbalances, we
performed transgenesis with a BAC carrying a large (127 kb)
intact genomic segment that includes the complete murine
Pten gene (see Figure S1A online). In this manner, we obtained
a transgenic mouse line, Ptentg, that expresses 2-fold levelsCeof Pten relative to their wild-type (WT) littermates across all
examined tissues, including mouse embryonic fibroblasts
(MEFs) (2.3 ± 0.4; Figure 1A). Transgenic mice were fertile and
viable, although analysis of the segregation of the Ptentg allele
indicated that the frequency of weaned transgenic mice was
lower than expected (50% lower) (Table S1). Examination of
embryos at an advanced stage of gestation (E13.5) showed
equal proportions of WT and transgenic genotypes (Table S1),
albeit transgenic embryos were noticeably smaller than WT
embryos (Figure S1B). We surmise that the small size of the
transgenic pups could cause abandonment by the mothers
and early postnatal lethality. It is worthmentioning that a similarly
high proportion of postnatal lethality has been reported for the
long-lived dwarf mice deficient in the growth hormone receptor
(Ghr) (Coschigano et al., 2003; Zhou et al., 1997). The function-
ality of the Pten transgene was validated genetically by its ability
to rescue the tumor-prone phenotype of Pten+/ mice and the
embryonic lethality of Pten/ embryos (Di Cristofano et al.,
1998; Podsypanina et al., 1999; Suzuki et al., 1998). Specifically,
Pten+/;tg mice had a longevity comparable to Pten+/+ micell Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc. 383
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Figure 2. Increased Longevity of Ptentg Mice
(A) Kaplan-Meier survival curves. Numbers in red indicate the relative increase
in median survival. The right bottom graph corresponds to those mice that
were free of detectable malignant tumors at the time of death. Statistical
significance was determined by the log rank test.
(B) DNA damage in the liver of old mice (1.5–2 years old; n = 4 males per
genotype). Percentage of positive nuclei by immunofluorescence using the
indicated markers (mean ± SD). Statistical significance was determined by the
two-tailed Student’s t test.
(C) Neuromuscular coordination. Tightrope assay in young (4–6 months) and
old (1.5–2 years) mice (mixed sexes) of the indicated genotypes (number of
mice that passed the test versus total number of tested mice). Statistical
significance was determined by the Fisher’s exact test.
*p < 0.05; ***p < 0.001. See also Figure S2.
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Pten Regulates Longevity and Brown Adipose Tissue(Figure S1C), and Pten/;tg embryos were viable and reached
adulthood (data not shown).
The impact of Pten overexpression on PI3K signaling was
confirmed in primary MEFs under standard culture conditions
in which the basal levels of Pten protein were clearly increased
in association with lower levels of phosphorylated Akt (phospho-
Ser473-Akt) (Figure 1B). Also, insulin-triggered PI3K signaling
was attenuated as judged by the levels of phospho-Ser473-Akt
and phospho-Thr308-Akt, as well as phospho-Thr24-Foxo1
and phospho-Thr32-Foxo3 (Figure 1C; Figure S1D). To evaluate384 Cell Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc.whether the Pten transgene had an effect on the proliferation of
MEFs, we measured their ability to form colonies at low density
and to accumulate population doublings upon serial passages.
In both assays, Ptentg MEFs demonstrated a poorer proliferative
capacity compared to WT MEFs (Figures 1D and 1E). Next, we
asked whether the Pten transgene was able to protect primary
MEFs from oncogenic transformation. For this, we introduced
into MEFs the papilloma virus oncoprotein E6, which inactivates
p53, together with either oncogenic EGFR (EGFRL858R) or poly-
oma virus oncoprotein middle-T, whose oncogenic activities
are known to be strictly dependent on PI3K signaling (Utermark
et al., 2007; Zhao et al., 2006). In both cases, Ptentg MEFs
were significantly more resistant than WT MEFs to oncogenic
transformation (Figure 1F). Finally, we examined whether tumor
suppression, the archetypical activity of Pten, was enhanced
in Ptentg mice. This was evaluated, first, using a chemical
carcinogenesis assay consisting of intramuscular injection of
3-methyl-cholanthrene (3MC). This cancer model generates
fibrosarcomas in all the treated mice, but Ptentg mice showed
a significantly extended tumor-free survival compared to
WTmice (Figure 1G). Additionally, we performed complete histo-
logical exploration of aged moribund mice and scored the
incidence of tumors (nonmalignant and malignant), as well as
other pathologies (Table S2). Interestingly, the percentage of
old moribund mice with cancer (i.e., malignant tumors) was
significantly reduced in the Ptentg group relative toWTmice (Fig-
ure 1H). Several cancer types, most notably lymphomas and
histiocytic sarcomas, were significantly reduced in the Ptentg
cohort (Figure 1H). These observations are in concordance
with the fact that Pten haploinsufficiency produces a variety of
tumor types, most notably including lymphomas (Di Cristofano
et al., 1998; Podsypanina et al., 1999; Stambolic et al., 2000).
We conclude that the Ptentg allele is functional and provides
protection against neoplastic transformation and cancer.
Ptentg Mice Live Longer
To address the impact of Pten on health span and longevity, we
followed cohorts of Ptentg mice, together with their WT litter-
mates, during their entire life span (Tables S3 and S4). Impor-
tantly, both male and female Ptentg mice showed a significant
increase in longevity as indicated by their Kaplan-Meier survival
curves,median survival, andmaximal life span (Figure 2A; Tables
S5 and S6; Figures S2A and S2B). In particular, the mean
longevity of the oldest 20% mice was significantly increased
both in males (+16%) and in females (+9%) (p values of 0.003
and 0.009, respectively), and the mean longevity of the oldest
10% of mice was also significantly increased in both sexes
(Table S6). Additional statistical tests (Cox regression) indicated
that the increased survival of Ptentg mice was dependent on the
transgene and independent of other variables, such as the iden-
tity of the parents or the date of birth (Table S7). We also
wondered whether the effect of the transgene in longevity was
a consequence of its protective effect on cancer. However,
cancer-free Ptentg mice also showed an increased longevity
when compared with cancer-free WTmice (Figure 2A). This indi-
cates that Ptentg extends longevity independently of its effect on
cancer protection and suggests a direct impact on health span.
The accumulation of DNA damage within tissues, and particu-
larly in the liver, is a robust biomarker of aging (Matheu et al.,
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Figure 3. Improved Insulin Sensitivity and Protec-
tion from Diet-Induced Steatosis in Ptentg Mice
(A) Fasting glucose and insulin, and its derived insulin
resistance index HOMA-IR (n = 5–7 males per genotype
and per age group). Young, 4–6 months old; old,
1.5–2 years old.
(B) Igf1 levels in serum (n = 4 males per genotype and per
age group). Age groups as in (A).
(C) Immunoblot of the indicated proteins from epididymal
WAT. Each lane corresponds to a different mouse. Irs1
corresponds to old male mice (1.5–2 years old).
(D) Insulin sensitivity of mice chronically fed with HFD
for 6 months. Insulin sensitivity was measured by ITT. The
graph to the right quantifies the area under the curve
(AUC).
(E) Macroscopic views of representative livers 6 months
after chronic HFD and microscopic sections stained with
hematoxylin and eosin (bar indicates 500 mm).
All values correspond to mean ± SD, and statistical
significance was determined by the two-tailed Student’s
t test. *p < 0.05; **p < 0.01. See also Figure S3.
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Pten Regulates Longevity and Brown Adipose Tissue2007; Wang et al., 2009). Immunofluorescence with two markers
of DNA damage, 53BP1 and gH2AX, indicated a significantly
lower level of DNA damage in the liver of old Ptentg mice
compared to WT controls (Figure 2B). Also, old transgenic
mice (1.5–2 years old) performed better in the tightrope test
than WT controls (Figure 2C), further suggesting improved
health span, although interpretation of this test could be
confounded by the different weight of the mice (see below).
We conclude that moderate overexpression of Pten improves
markers of healthy aging and increases longevity independently
of cancer protection.
Ptentg Mice Are Protected from Insulin Resistance
and Steatosis
A widespread feature of long-lived mice with decreased IIS axis
activity is their improved insulin sensitivity (Bartke, 2008). This
effect, apparently paradoxical, is explained by the concomitant
reduction in the negative feedback routes that emanate from
the insulin signaling pathway (Carracedo and Pandolfi, 2008;
Kamagate et al., 2010; Matsumoto et al., 2006; Puig and Tjian,
2005). In keeping with this, Ptentg mice, both young (4–6 months
old) and old (1.5–2 years old), had lower fasting levels of glucose
and insulin serum levels (Figure 3A), and a significantly lower
value of the insulin resistance index HOMA-IR (Figure 3A) (see
also QUICKI index in Figure S3A). Also, serum levels of Igf1
were significantly, albeit moderately, lower in Ptentg miceCell Metabolism 15,compared to WT mice, at both young and old
ages (Figure 3B). To explore the role of negative
feedback signals in white adipose tissue (WAT),
we examined the levels of S6K activity, which is
a main activity responsible for negative feed-
back signaling (Um et al., 2004, 2006). As ex-
pected, the WAT of Ptentg mice presented
reduced levels of phosphorylated Akt and, inter-
estingly, lower levels of phosphorylation in two
relevant substrates of S6K, namely S6 and Irs1
(Figure 3C). S6K-mediated phosphorylation ofIrs1 at Ser636/639 is inhibitory for insulin signaling and, analo-
gously to the phenotype of S6K1 null mice (Um et al., 2004),
the lower activity of S6K in Ptentg mice could explain their
improved insulin sensitivity. To further challenge this concept,
we fed mice with high-fat diet (HFD) for 6 months, which is
a well-established metabolic stress that produces insulin resis-
tance and liver steatosis. Under HFD, Ptentg mice increased their
body weight to a relative extent similar to that of WT mice (Fig-
ure S3B). However, upon injection of insulin (insulin tolerance
test, ITT), HFD-fed WT mice were unresponsive to insulin, while
HFD-fed Ptentg mice responded to insulin with a significant
decrease in glucose levels (Figure 3D). Moreover, HFD-fed WT
mice had overt liver steatosis, while HFD-fed Ptentg mice had
minimal or no signs of steatosis (Figure 3E). All together, we
conclude that moderate and regulated overexpression of Pten
results in improved insulin sensitivity and in protection from the
damaging effects of HFDs.
Increased Energy Expenditure in Ptentg Mice
In an effort to shed light onto the physiological mechanisms
involved in the extended life span ofPtentg mice and their protec-
tion against damage induced by nutrient overload, we have
explored their metabolism. Ptentg mice presented a decreased
body weight (Figure 4A) (27% and 28% decrease in young
[4–6 months old] male and female mice, respectively, and 35%
and 44% in old [1–2 years old] males and females; Figure S4A).382–394, March 7, 2012 ª2012 Elsevier Inc. 385
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Figure 4. Elevated Energy Expenditure and
Decreased Adiposity in Ptentg Mice
(A) Weight curves (n = 15 for each genotype and
sex).
(B) Food intake in absolute values (left) and
normalized by body weight (right) (n = 8 males per
genotype; 3–4 months old).
(C) Energy expenditure measured in adult males
and females (6–8 months old; n = 8–10 per geno-
type and per sex). The bar graph at the right side
represents the AUC over the indicated 12 hr
period.
(D) Resting metabolic rate measured at the indi-
cated temperatures in adult males (6–8 months
old; n = 7–9 per genotype).
(E) Adiposity in youngmice (6–8 months old; n = 8–
10 per genotype and per sex) measured by dual
energy X-ray absorptiometry (DXA). Values corre-
spond to the percentage of fat relative to the sum
of lean and fat masses.
(F) Leptin and cholesterol levels in the serum of
young mice (n = 8 males per genotype; 6 months
old).
(G) Representative picture of epididymal WAT.
Samples correspond to young males and were
stained with hematoxylin and eosin (bar indicates
100 mm) (left). Adipocyte area distribution is
shown (n = 2 per genotype; >500 cells per geno-
type) (right).
All values correspond tomean ± SD, and statistical
significance was determined by the two-tailed
Student’s t test. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S4.
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Pten Regulates Longevity and Brown Adipose TissueInterestingly, this lower weight occurred despite the fact that
Ptentg mice were hyperphagic (Figure 4B and Figure S4B). We
wondered whether this could be a result of increased energy
expenditure. Indirect calorimetry indicated that Ptentg mice
have an increased energy expenditure relative to their total
body weight and under normal housing conditions (23C and
access to water and food) (Figure 4C). Following recent recom-
mendations on how to compare energy expenditure between
groups with different body weights (Arch et al., 2006; Kaiyala
and Schwartz, 2011), we applied more stringent statistical
tests (general linear model [GLM] and analysis of covariance
[ANCOVA]). However, applying these tests we could not detect
a significant impact of the transgene on energy expenditure
under these conditions. To improve the sensitivity of the calori-
metric measurements, we scored the resting metabolic rate
(RMR) at 23C and, more importantly, at 30C (thermoneutrality)
in the absence of water and food. This minimizes the contribu-
tions of physical activity, food processing, and body temperature
maintenance on energy expenditure, thus allowing a more accu-
rate evaluation of the differences in basal metabolism. Moreover,
due to the different body composition of the Ptentg mice (see386 Cell Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc.below), we followed recent recommenda-
tions regarding the use of lean mass
rather than total body weight for normali-
zation (Butler and Kozak, 2010). Impor-
tantly, Ptentg mice had an increased
RMR relative to lean mass, both at 23C
and 30C (Figure 4D). Furthermore, in this case, GLM and
ANCOVA analyses indicated that the transgene has a statistically
significant impact on metabolic rate, which is independent of its
effect on lean mass (Figure S4C). No significant changes were
detected in the respiratory quotient (Figure S4D). Locomotor
activity and body temperature were similar between the two
cohorts of mice (Figures S4E and S4F), thus excluding these
factors as possible explanations for the increased energy expen-
diture, and implying an elevated metabolic rate as responsible
for the observed increase in energy expenditure.
High levels of energy expenditure are generally associated
with reduced nutrient storage and protection from metabolic
damage. In support of this, dual energy X-ray absorptiometry
(DXA) indicated that Ptentg mice had a relative decrease in fat
mass (Figure 4E; Figure S4G). Also, compared to WT controls,
the weight of the epididymal WAT relative to body weight was
significantly lower in transgenic males (Figure S4H), and their
serum levels of leptin and cholesterol were reduced compared
to WT mice (Figure 4F). Finally, the size of the adipocytes in
the epididymal WATwas smaller (Figure 4G). Incidentally, adipo-
nectin and thyroxine levels were normal in Ptentg mice
Cell Metabolism
Pten Regulates Longevity and Brown Adipose Tissue(Figure S4I). Together, these results indicate that moderate upre-
gulation of Pten results in increased energy expenditure and
lower adiposity.
Ptentg Mice Have a Hyperactive BAT
An efficient mechanism to dissipate energy is through brown
adipocytes, which are located both at the brown adipose tissue
(BAT) and also interspersed within the WAT (Kozak and Anun-
ciado-Koza, 2008; Nedergaard and Cannon, 2010). Brown
adipocytes have gained considerable attention since the recent
recognition of their relevance in adult humans (Cypess et al.,
2009; Lidell and Enerback, 2010; van Marken Lichtenbelt et al.,
2009; Virtanen et al., 2009). Moreover, in mice, the magnitude
of nutrient uptake by the BAT is comparable to that of the liver
under normal temperature and diet conditions (Bartelt et al.,
2011; Nedergaard et al., 2011). Macroscopically, the interscap-
ular BAT of Ptentg mice had a more intense color compared to
WT BAT and, histologically, it presented a denser appearance
due to reduced size of the multilocular lipid droplets (Figure 5A),
which is suggestive of higher BAT activity. To directly assess the
constitutive activity of the BAT, we measured 18F-deoxyglucose
(FDG) uptake by positron emission tomography (PET). Impor-
tantly, the uptake of glucose was significantly higher in the
BAT of Ptentg mice compared to the BAT of WTmice (Figure 5B).
Energy dissipation in brown adipocytes is mediated by the un-
coupling protein Ucp1 (Nicholls and Locke, 1984). Remarkably,
the expression levels of Ucp1 were significantly higher in the
BAT of Ptentg mice compared to their WT littermates (Figure 5C).
In relation to this, it is worth mentioning that mice lacking the
insulin receptor (IR) in the BAT also present higher levels of
Ucp1 expression (Guerra et al., 2001).
The transcriptional coactivator Pgc1a is a critical positive
regulator of Ucp1 expression and regulates multiple metabolic
responses including the induction of fatty acid oxidation (Puig-
server and Spiegelman, 2003; Puigserver et al., 1998; Vega
et al., 2000). Interestingly, Pgc1a and some genes involved in
fatty acid oxidation were also significantly upregulated in the
BAT of Ptentg mice (Figure 5C). Other genes expressed in brown
adipocytes were not significantly altered (Figure S5A). In the
liver, the transcriptional factor Foxo1 is an essential partner for
the function of Pgc1a (Matsumoto et al., 2007; Puigserver
et al., 2003), and Akt phosphorylates and inhibits both Pgc1a
(Li et al., 2007) and Foxo proteins (Kops et al., 1999; van der
Horst and Burgering, 2007). Based on this, we examined
whether the BAT of Ptentg mice also had lower levels of phos-
phorylated Akt and Foxo1. Indeed, immunodetection of these
proteins revealed that transgenic BAT had lower levels of active
Akt (phospho-Ser473-Akt) as well as lower levels of phosphory-
lated Foxo1 (phospho-Thr24-Foxo1) (Figure 5D). Incidentally, we
wondered whether CR would exert a similar transcriptional
response in the BAT, but mice under CR for 4 weeks presented
lower, rather than higher, levels of Pgc1a and normal levels of
Ucp1 in the BAT (Figure S5B).
Both Pgc1a and Ucp1 are characteristically expressed in
brown, but not in white, adipocytes (Puigserver and Spiegelman,
2003; Puigserver et al., 1998), and therefore their detection in
WAT is indicative of the presence of brown adipocytes within
WAT (Kozak and Anunciado-Koza, 2008; Nedergaard and
Cannon, 2010). Analysis of subcutaneous WAT (inguinal, iWAT)Ceshowed significantly higher levels ofPgc1a andUcp1 expression
in transgenic mice compared to WT mice (Figure 5E), and histo-
logical analyses and Ucp1 immunohistochemistry detected the
presence of abundant brown adipocytes interspearsed within
white adipocytes (Figure 5F). Increased levels of Pgc1a and
Ucp1 were also found in visceral WAT (epididymal, eWAT) (Fig-
ure S5C). Together these observations indicate widespread
presence of brown adipocytes within the WAT of Ptentg mice.
In addition to brown adipocytes, muscle is another important
tissue responsible for energy expenditure. In particular, overex-
pression of Pgc1a or small compounds that activate Pgc1a
through Sirt1 induce a change in muscle myofibers from type II
(low oxidative capacity) to type I (high oxidative capacity), and
this is associated with increased energy expenditure (Feige
et al., 2008; Lin et al., 2002). Examination of succinate dehydro-
genase in the gastrocnemius muscle (containing both types of
myofibers), as well as the expression levels of genes character-
istic of type I and type II myofibers, oxidative phosphorylation
genes, and mitochondrial DNA, did not reveal differences
between WT and Ptentg mice (Figure S5D). This reinforces the
idea that the increased energy expenditure observed in Ptentg
mice is at least partially due to a higher activity of brown
adipocytes.
The above observations demonstrating an increased activity
of brown adipocytes in Ptentg mice could be due, at least to
some extent, to the small body size of these mice, which implies
higher rates of body heat loss. To study the intrinsic effect of
PI3K inhibition on brown adipocyte function, we undertook two
approaches: to analyze the role of the PI3K pathway on isolated
cells, and to examine the effect of pharmacological inhibition of
PI3K in WT mice (see further below). To study the regulation of
brown adipocyte function in vitro, we established immortalized
cultures of neonatal brown adipocytes (undifferentiated pre-
brown adipocytes) from WT and Ptentg mice. Compared to WT
pre-brown adipocytes, Ptentg pre-brown adipocytes presented
significantly higher levels of Pten, Pgc1a, and Ucp1 mRNA and
lower levels of phosphorylated Akt and Foxo1 (Figure 5G). To
directly evaluate the thermogenic activity of pre-brown adipo-
cytes, we measured the rate of respiration (oxygen consumption
rate, OCR) in the absence or presence of oligomycin (Dranka
et al., 2011). Interestingly, the proton leakage rate (respiration
in the presence of oligomycin) was significantly higher in Ptentg
pre-brown adipocytes than in their WT counterparts (Figure 5H).
To further support the cell-autonomous impact of Pten in pre-
brown adipocytes, we reduced the levels of Pten in WT pre-
brown adipocytes using shRNAs against Pten. As hypothesized,
this resulted in lower levels of Pgc1a and Ucp1 (Figure S5E).
Finally, to directly test the implication of Foxo1, retroviral expres-
sion of constitutively active Foxo1, Foxo1-AAA (Nakamura et al.,
2000), induced both Pgc1a and Ucp1, as well as Sod2, a known
transcriptional target of Foxo1 (Figure S5F). Taken together,
these results demonstrate that Pten is a positive regulator of
brown adipocyte function, and this can at least partially explain
the increased energy expenditure of Ptentg mice.
Pten Improves the Reprogramming of Fibroblasts
into BAT
The above results indicate that Pten has cell-autonomous effects
that can be recapitulated in vitro with cultured brown adipocytes.ll Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc. 387
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Figure 5. Hyperactive BAT in Ptentg Mice
(A) Representative macroscopic pictures of BAT (left, bar indicates 1 cm). Microscopic pictures of BAT stained with hematoxylin and eosin (right, bars indicate
100 mm). Samples correspond to males (5 months old).
(B) 18F-fluor-deoxyglucose (FDG) uptake measured by PET. Representative pictures (left). Relevant organs are indicated in addition to BAT: bl, bladder; h, heart;
br, brain. Analyses were done in males (6 months old; n = 5 per genotype). Quantification of the average FDG uptake activity (standard uptake value average,
SUVave) of the BAT (right).
(C) Relative gene expression in BAT (5 months old; n = 3–6 males per genotype).
(D) Immunoblot of BAT lysates (5 months old; n = 5 males per genotype).
(E) Relative gene expression in inguinal WAT (3–6 months old; n = 3 males per genotype).
(F) Representative histology and Ucp1 immunohistochemistry of the inguinal WAT from the mice in (E). Bars indicate 200 mm in high magnification pictures and
50 mm in low magnification pictures.
(G) Relative gene expression (left) and protein levels (right) in pre-brown adipoctyes (performed in triplicate cultures).
(H) Respiration rate in the absence or presence of oligomycin (oligo) in pre-brown adipocytes (values correspond to the mean ± SEM of six independent assays).
Values in all panels, except (H), correspond to mean ± SD. Statistical significance was determined by the two-tailed Student’s t test. *p < 0.05; **p < 0.01;
***p < 0.001. See also Figure S5.
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Figure 6. Reprogramming of Ptentg MEFs
into BAT
(A) Gene expression in MEFs programmed with
Prdm16/Cebpb before differentiation (pre) and
after differentiation (post) into brown adipoctyes.
Values correspond to the mean ± SD (n = 3) and
are relative to predifferentiation WT MEFs. For
comparison, pre-brown adipocytes were also
differentiated in parallel.
(B) Representative microscopic pictures of BAT
implants derived from Prdm16/Cebpb-prog-
rammed WT or Ptentg fibroblasts. Sections were
stained with hematoxylin and eosin (H&E) or with
anti-Ucp1 (Ucp1). Bars correspond to 200 mm.
Additional pictures are shown in Figure S6.
(C) Amount of BAT formation by Prdm16/
Cebpb-programmed WT or Ptentg fibroblasts.
Each value corresponds to the area of BAT (in
arbitrary units) measured in the fat pads formed
per injection site (n = 8 forWT, and n = 7 for Ptentg).
Statistical significance was determined by the
two-tailed Student’s t test. *p < 0.05; ***p < 0.001.
See also Figure S6.
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transcriptional factor Prdm16 and its cofactor Cebpb, whose
combined expression is able to program fibroblasts to become
brown adipocytes upon in vitro differentiation and to form
BAT-containing fat pads upon subcutaneous implantation (Kaji-
mura et al., 2009; Seale et al., 2007). ImmortalizedWT and Ptentg
MEFs were programmed with retroviruses encoding Prdm16
and Cebpb. Interestingly, upon in vitro differentiation into brown
adipocytes, Prdm16/Cebpb-programmed MEFs showed an up-
regulation of Pten mRNA levels, which was also observed when
pre-brown adipocytes were differentiated (Figure 6A and Fig-
ure S6A). This suggests that Pten may play an active role during
brown adipocyte differentiation. To directly test this in a more
physiological context, Prdm16/Cebpb-programmed MEFs
were injected subcutaneously into nude mice. Twomonths later,
fat pads with depots of BAT were identified at the injection sites
(Figure 6B and Figure S6B). Quantification of the amount of BAT
indicated that Ptentg cells were significantly more efficient at
generating BAT than their WT counterparts (Figure 6C). These
results confirm that Pten exerts a cell-autonomous effect on
BAT even in the in vivo context of a nontransgenic host (i.e.,
the nude mice used as host), and open a route to improve the
generation of BAT implants.
Activation of BAT by PI3K Inhibitors
Themechanisms of action of Pten could go beyond the inhibition
of PI3K (Song et al., 2011). To establish the involvement of PI3KCell Metabolism 15, 382–3on the above reported effects of Pten in
BAT, we inhibited PI3K using a small
compound inhibitor of PI3K developed
at the Spanish National Cancer Research
Center (CNIO), named CNIO-PI3Ki (see
the Experimental Procedures and Fig-
ure S7A). First, we tested the effects ofCNIO-PI3Ki in a total of three different models of brown adipo-
cytes and in the absence or presence of forskolin, an activator
of AMP cyclase that mimics b-adrenergic stimulation and upre-
gulates Ucp1 levels (Puigserver et al., 1998). Specifically, we
used pre-white adipocytes 3T3-L1 ectopically expressing
Cebpb and then differentiated into brown adipocytes (Karaman-
lidis et al., 2007) (Figure S7B), which can be considered a model
of white-to-brown transdifferentiation; we also used immortal-
ized neonatal pre-brown adipocytes under proliferative condi-
tions and after in vitro differentiation. Treatment of these cellular
models of brownadipocyteswithCNIO-PI3Ki resulted in a severe
decrease in the levels of phospho-Akt (Figure 7A) and upregula-
tion of Pgc1a and Ucp1, both alone and in combination with for-
skolin (Figure 7B). Moreover, treatment of pre-brown adipocytes
with two other structurally unrelated inhibitors, namely GDC-
0941 and LY-294002, also produced efficient induction of
Pgc1a and Ucp1 (Figure S7C). These results indicate that inhibi-
tion of PI3K with small compounds activates brown adipocyte
function in a cell-autonomous manner. To gain additional mech-
anistic insight into how CNIO-PI3Ki activates the expression of
Pgc1a and Ucp1, we tested binding of Foxo1 to the promoters
of these genes by chromatin immunoprecipitation in differenti-
ated brown adipocytes and in 3T3-L1/Cebpb cells. Importantly,
CNIO-PI3Ki, but not forskolin, induced the binding of Foxo1 to
the promoter regions of Pgc1a and Ucp1 (Figure 7C and Fig-
ure S7D). To examine the effect of CNIO-PI3Ki on brown adipo-
cyte function, wemeasured the rate of proton leakage both in the94, March 7, 2012 ª2012 Elsevier Inc. 389
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Figure 7. Recapitulation of the Effects of Pten on BAT with a PI3K Inhibitor
(A) Immunoblot of the indicated cells treated with CNIO-PI3Ki in the presence or absence of forskolin. For (A) and (B), cells were treated with forskolin (10 mM) and/
or the CNIO-PI3Ki (1 mM for 3T3-L1/Cebpb cells and pre-brown adipocytes, and 10 mM for differentiated brown adipocytes) and analyzed 4 hr later.
(B) Relative mRNA levels in the indicated cells (n = 3 independent biological repeats).
(C) ChIP of Foxo1 and PCR amplification of the Ucp1 and Pgc1a promoters in differentiated brown adipocytes. Data correspond to a triplicate PCR. Similar data
were obtained in a total of two assays.
(D) Respiration rate in the absence or presence of oligomycin (oligo) in differentiated brown adipocytes treated or not with CNIO-PI3Ki (10 mM) for 4 hr before
measurement (values correspond to the mean ± SEM of four independent assays).
(E) Relative mRNA levels in BAT upon CNIO-PI3Ki (15 mg per kg of body weight) or vehicle administration, by gavage (3 months old; n = 3 males C57BL6 per
group) (left). Samples were analyzed 6 hr after administration. Pictures correspond to representative images of the BAT stained with H&E or with anti-Ucp1 (Ucp1)
(bars indicate 200 mm in high-magnification pictures and 50 mm in low-magnification pictures) (right).
(F) Relative mRNA levels in inguinal WAT (3 months old; n = 3 males per genotype).
(G) Energy expenditure (area under the curve) and resting metabolic rate were measured at 30C in mice (3 months old; n = 5males) treated with vehicle or CNIO-
PI3Ki (15 mg/kg). Recordings from 1 to 7 hr posttreatment (a total of 6 hr) were analyzed.
(H) Summary of the effects of PI3K downregulation, by Pten or PI3Ki, on Ucp1 in brown adipocytes.
Values in all panels, except (D), correspond to mean ± SD. Statistical significance was determined by the two-tailed Student’s t test. *p < 0.05; **p < 0.01;
***p < 0.001. See also Figure S7.
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strongly enhanced the proton leak (rate of respiration in the pres-
ence of oligomycin) of forskolin-activated brown adipocytes,
while its effects were modest in the absence of activation by for-
skolin (Figure 7D). To further validate our data with CNIO-PI3Ki,
micewere treatedwith this compound, and this resulted in signif-
icant upregulation of Ucp1 and Pgc1a, together with some other
genes involved in fatty acid oxidation in the BAT (Figure 7E),
while the expression of other genes remained unaltered (Fig-
ure S7E). In addition, histology showed a decrease in the
amount of lipid droplets and a more intense immunohistochem-
ical staining of Ucp1 in the BAT of CNIO-PI3Ki-treated mice
(Figure 7E). Moreover, the inguinal WAT of the treated mice
also showed increased levels of Ucp1mRNA (Figure 7F). Finally,
we wanted to test whether these effects had a reflection in
energy expenditure (EE), RMR, and oxygen consumption (VO2),
all measured at 30C and in the absence of food and water.
Importantly, CNIO-PI3Ki-treated mice showed an increase in
EE, RMR, and VO2 during the analyzed period of 6 hr (from +1 hr
to +7 hr postadministration) (Figure 7G and Figure S7F).
Together, these results indicate that downregulation of PI3K
can account for the hyperactive BAT and increased energy
expenditure of Ptentg mice. Moreover, we also conclude that
the effects of PI3K inhibition on brown adipocyte activity are
cell autonomous.
DISCUSSION
In worms and flies, the IIS longevity pathway is intracellularly
mediated by the PI3K/Akt/Foxo pathway, where the most
accepted view is that Foxo proteins orchestrate an array of
protective responses, including antioxidant defenses (Fontana
et al., 2010). In mammals, however, the picture is much less
complete. Mice with defects in the receptors or Irs adaptors
for insulin and Igf1 present increased longevity (Selman and
Withers, 2011). Our findings that Pten transgenic mice have an
increased life span contribute to extend the evolutionary conser-
vation of this longevity pathway to mammals. However, the
underlying mechanisms remain poorly understood despite
intense investigation (Bartke, 2008; Fontana et al., 2010; Selman
andWithers, 2011). Ptentg mice present a number of phenotypes
that have been associated to longevity in other long-lived mouse
models. These phenotypes include reduced body size (Chen
et al., 2010; Miller et al., 2002), reduced levels of Igf1 and
improved insulin sensitivity (Bartke, 2008; Chen et al., 2010),
and increased energy expenditure (Mookerjee et al., 2011). All
these phenotypes could conceivably underlie the increased
longevity of Ptentg mice.
Given the lack of precedents linking Pten to energy expendi-
ture, we have characterized this phenotype in further depth.
Using rigorous calorimetric tests, we demonstrate that trans-
genic Pten mice have an increased energy expenditure, which
is associated with lower adiposity and lower bodyweight despite
being hyperphagic. Energy expenditure is a leading concept in
metabolism that is emerging as a relevant determinant of
longevity. Notably, a positive association has been reported
between the individual values of energy expenditure of young
mice and their subsequent life span (Speakman et al., 2004).
The impact of energy expenditure on physiology and longevityCeis multifaceted. Energy expenditure associated to mitochondrial
uncoupling protects cells frommitochondrial damage according
to the so-called ‘‘uncoupling to survive’’ hypothesis (Brand,
2000; Mookerjee et al., 2011). Even if restricted to a specific
tissue, increased energy expenditure has important systemic
beneficial effects by consumption of nutrients, which are thereby
diverted from storage and its associated systemic damage. For
example, relevant for our work, localized overexpression of Ucp1
in muscle improves insulin sensitivity, protects mice under HFD
from obesity and insulin resistance, and increases longevity
(Gates et al., 2007; Li et al., 2000). Also, lifelong treatment of
mice with a mitochondrial uncoupler increases energy expendi-
ture and extends longevity (Caldeira da Silva et al., 2008).
Consistent with their increased energy expenditure, Ptentg
mice present a number of systemic beneficial effects on health,
including improved insulin sensitivity, protection from HFD-
induced diabetes and steatosis, and protection from DNA
damage associated to aging in the liver, which together are likely
to contribute to the extended longevity of these mice.
The BAT is the paramount tissue specialized in energy dissipa-
tion through mitochondrial uncoupling. In mice under standard
conditions of temperature and diet, the BAT is responsible for
an amount of nutrient combustion that is similar in magnitude
to the liver or the brain (Bartelt et al., 2011; Nedergaard et al.,
2011). The potential relevance of the BAT to combat human
obesity is based on highly suggestive correlative studies (Cypess
et al., 2009; Lidell and Enerback, 2010; van Marken Lichtenbelt
et al., 2009; Virtanen et al., 2009). We show with a variety of
assays, including histology, functional glucose uptake, and
gene expression, that the BAT of Ptentg mice is hyperactive.
This has been confirmed in in vitro assays using isolated brown
adipocytes, thus indicating that the effects of Pten on brown
adipocytes are, at least in part, cell autonomous. Molecular
analyses, including the use of several small compound inhibitors
of PI3K, have allowed us to demonstrate that the effects of Pten
on brown adipocytes are mediated by the PI3K/Akt/Foxo
signaling pathway that results in the activation of Ucp1 and its
transcriptional regulator Pgc1a (Figure 7H). Importantly, the
small compoundCNIO-PI3Ki can recapitulate in vivo the upregu-
lation of Ucp1 and Pgc1a in the BAT, and results in increased
energy expenditure. Moreover, the role of Pten on brown adipo-
cyte function has been reinforced by its ability to improve
the generation of subcutaneous BAT implants from Prdm16/
Cebpb-programmed fibroblasts. Despite these evidences, we
cannot exclude that Pten or pharmacological inhibition of PI3K
could stimulate energy expenditure through other mechanisms
in addition to the activation of brown adipocytes.
In summary, we propose that Pten is a positive regulator of
energy expenditure, with a dramatic and cell-autonomous effect
in the BAT. A consequence of the increased energy expenditure
is a systemic protection against metabolic damage, including
aging-associated insulin resistance and aging-associated DNA
damage in the liver. An interesting corollary of our work is the
possibility of mimicking the effects of Pten overexpression with
a small compound PI3K inhibitor. In a wider scope and together
with our previous reports (Matheu et al., 2007, 2009), the four
main tumor suppressors, namely p53, Ink4a, Arf, and Pten,
improve organismal survival independently of their effects on
cancer. This reinforces the concept that these important tumorll Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc. 391
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cancer and have multiple protective functions.
EXPERIMENTAL PROCEDURES
Transgenesis
Transgenesis was performed using a BAC, RP24-372O16 (obtained from
CHORI; http://www.chori.org/) (Figure S1A) and following previously
described procedures (Pfluger et al., 2008). Unless otherwise specified, all
the mice used in this study are C57BL6/CBA (75%:25%). All animal proce-
dures were performed according to protocols approved by the CNIO-ISCIII
Ethics Committe for Research and Animal Welfare (CEIyBA). For additional
details, see the Supplemental Experimental Procedures.
Indirect Calorimetry
Indirect calorimetry was performed following standard methods using Oxylet
System metabolic chambers (Panlab Harvard Apparatus). To measure the
effect of CNIO-PI3Ki on EE, RMR, and VO2 mice were acclimated for 1 week
at 30C. On the day of analysis, mice were deprived of food and water at
08:00 hr, the compound (15 mg/kg) or its vehicle was administered by gavage
at 10:00, andmice were placed in the metabolic chambers. Recordings of VO2
and VCO2 from 11:00 to 17:00 were used to calculate EE and RMR. For addi-
tional details, see the Supplemental Experimental Procedures.
Measurement of Glucose Uptake by PET
PET analysis was performed following optimized methods previously
described by us (Mulero et al., 2011). For additional details, see the Supple-
mental Experimental Procedures.
Cellular Assays
Isolation and experimentation with MEFs, brown adipocytes, and 3T3-L1 cells
were performed using previously established methods. For additional details,
see the Supplemental Experimental Procedures.
Reprogramming of MEFs into BAT
In vitro programming of MEFs and subsequent implantation to generate brown
adipocytes were performed essentially as previously described (Kajimura
et al., 2009). For additional details, see the Supplemental Experimental
Procedures.
Measurements of Oxygen Consumption Rate
OCR of brown adipocytes was measured in a Seahorse Bioscience XF24
Extracellular Flux Analyzer (North Billerica, MA, USA). For additional details,
see the Supplemental Experimental Procedures.
PI3K Inhibitors
The low molecular weight compound CNIO-PI3Ki is covered by patent
WO2010/119264 (files available at the World Intellectual Property Organiza-
tion, http://www.wipo.int/pctdb/en/wo.jsp?WO=2010119264). This is a potent
inhibitor of PI3K isoforms p110a (Ki = 2.4 nM) and p110d (Ki = 9.8 nM) (inhibi-
tion of the other PI3K isoforms, p110b and p110g, has values of Ki > 100 nM,
and inhibition of a total of 282 additional kinases including mTOR and DNAPK
requires concentrations of IC50 > 1 mM). For in vitro assays, CNIO-PI3Ki was
added at a concentration of 1 mM or 10 mM in DMSO, as indicated. For in vivo
assays, CNIO-PI3Ki was administered orally by gavage at a dose of 15 mg/kg
in 90% PEG-300 and 10% N-methyl-2-pyrrolidone. Treated mice were
C57BL6 males, 3 months old. Mice were sacrificed 6 hr later and tissues
were extracted and analyzed. The small PI3K inhibitor GDC-0941 was ob-
tained from Shanghai Haoyuan Chemexpress, and LY-294002 was obtained
from CalBiochem. Both inhibitors were dissolved DMSO.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, seven tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at doi:10.1016/j.cmet.2012.02.001.392 Cell Metabolism 15, 382–394, March 7, 2012 ª2012 Elsevier Inc.ACKNOWLEDGMENTS
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